Open AccessTargeted Chemotherapy vs. Immuno-Based Therapies in AML
Author(s) -
Richard Simoneaux
Publication year - 2018
Publication title -
oncology times
Language(s) - Uncategorized
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000549804.67911.7f
Subject(s) - midostaurin , medicine , myeloid leukemia , cytarabine , oncology , targeted therapy , cancer research , tyrosine kinase , cancer , pharmacology , receptor